Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Lymphoma × Clear all

Phase

Phase NA 50 Phase 1 49 Phase 2 43 Phase 1/2 43 Phase 3 9 Phase EARLY_PHASE1 8 Phase 2/3 4 Phase 4 1

Status

Completed 15 Unknown 11 Not yet recruiting 2 Withdrawn 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 30 Prostatic Neoplasms 12 Neoplasms 12 Carcinoma, Hepatocellular 9 Multiple Myeloma 8 Colorectal Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Papillomavirus Infections 7 Lung Neoplasms 7 Stomach Neoplasms 6 Pain, Postoperative 6 Liver Neoplasms 5 Recurrence 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Kidney Neoplasms 4 Heart Failure 4 Warts 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Skin Neoplasms 3 Pituitary Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Non-Muscle Invasive Bladder Neoplasms 3 Neuroendocrine Tumors 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Febrile Neutropenia 3

Interventions

fluarix 1 arexvy 1 abrysvo 1 Influenza Vaccines 1 Heplisav-B 1 FluLaval 1 BNT162 Vaccine 1 Afluria 1 23-valent pneumococcal capsular polysaccharide vaccine 1 13-valent pneumococcal vaccine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡